Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Damona Pharmaceuticals is a pre-clinical pharmaceutical company treats and prevents cognitive deficits.
Thryv Therapeutics is a precision medicine approach to treat patients with Long QT Syndrome and potentially other arrhythmias.
Spectrawave is a medical device company that develops optical diagnostic and therapeutic devices.
Aurinia develops and commercializes therapies to treat targeted patient populations suffering from serious auto-immune diseases.
Cour Pharmaceuticals Development is developing nanoparticle technology to help reset the immune system of multiple sclerosis (MS) patients.
Notch develops immune cell therapy developing a next-generation pipeline that is compatible and focuses on initial cancer cells.
Edesa develops treatments for dermatological and anorectal diseases. Edesa merged with Stellar Biotechnologies in 2019.
Nervonik is a medical device company developing an opioid-free peripheral nerve stimulation (PNS) system.
Congruence Therapeutics operates as a biotechnology company.
Specific Biologics develops novel gene editing technologies to treat diseases at the genetic level in cells inside the body.
Corvia Medical develops transcatheter device designed to reduce the symptoms or slow the progression of heart failure.
Bardy Diagnostics is a developer of a cardiac monitor and arrhythmia detection device .
Canadian company specializing in the development of a minimally invasive long-term hemodynamic transcatheter pump.
Sound Blade Medical is an early stage medical device startup which transforms healthcare by developing endoscopic, image-guided histotripsy.
XyloCor Therapeutics is a biopharmaceutical company intended to develop gene therapy for people with coronary artery disease.
KisoJi Biotechnology is a biotechnology company focused on healthcare and life sciences for research and development industries.
Endogenex develops an endoscopic procedure to help patients with type 2 diabetes regain control of their blood glucose levels.
Early stage biotechnology company
OncoMyx Therapeutics develops oncolytic immunotherapies to assist in creating an immune response and treat cancer.
AmacaThera's injectable hydrogel platform provides localized, sustained drug delivery to improve patient outcomes.
Cyrano Therapeutics is developing an intranasal product designed to restore function in patients with a chronic loss of taste and smell.
Antios Therapeutics is a biopharmaceutical company developing innovative therapies for viral diseases.
Medexus Pharma is a rare disease pharmaceutical company focusing on therapeutic areas of rheumatology and auto-immune conditions.
Axonis Therapeutics is a neuro-focused biotechnology company that focuses on the development of novel neuromedicines.
Lumira Ventures has invested in 41 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Lumira Ventures's top investment sectors include Biotechnology, Medical, Health Care, Therapeutics, Medical Device. The firm invests across 13 different industry categories.
Among tracked funding rounds, Axonis Therapeutics received $115.0M in a Series A round. Lumira Ventures's total known invested capital is $1.3B.
Lumira Ventures's average investment size is $36.4M across its portfolio of 41 companies.
Recent Lumira Ventures portfolio additions include Damona Pharmaceuticals, Thryv Therapeutics, Spectrawave, Aurinia Pharmaceuticals, Cour Pharmaceuticals Development. These companies were founded in 2020 or later.